Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 6/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL11027649 | 0.94 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Ethyl Acetate SCHEMBL2264348 | 0.94 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Ethyl Acetate SCHEMBL29257732 | 0.94 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Ethyl Acetate SCHEMBL27622625 | 0.91 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Ethyl Acetate SCHEMBL8340468 | 0.91 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Hexane SCHEMBL5393958 | 0.91 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Ethyl Acetate SCHEMBL27623309 | 0.91 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Ethyl Acetate SCHEMBL4336716 | 0.91 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Ethyl Acetate SCHEMBL4323421 | 0.91 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 | |
| Ethyl Acetate SCHEMBL2675053 | 0.91 | ALDH1A1 (0.64) | ALDH1A1LMNAHSD17B10TSHRCYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116650580-B | Daphne giraldii Nitsche product and preparation method and application thereof | 秦皇岛市山海关药业有限责任公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-116650580-A | Daphne giraldii Nitsche product and preparation method and application thereof | 秦皇岛市山海关药业有限责任公司 | 2023-08-29 | — | — | CN | disclosed |
| US-20220162209-A1 | SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2022-05-26 | — | — | US | disclosed |
| US-7989430-B2 | Antibacterial agents | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2011-08-02 | — | — | US | disclosed |
| US-20080293666-A1 | Antibacterial Agents | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162209-A1 | SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF | ADSL, SLC35B2, ADORA1 | ALDH1A1 136/4885LMNA 3181/4885HSD17B10 3491/4885 |
| US-20080293666-A1 | Antibacterial Agents | MRPL21, ABCB7, MSR1 | ALDH1A1 1972/4885LMNA 2265/4885HSD17B10 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.